XML 44 R19.htm IDEA: XBRL DOCUMENT v2.4.1.9
Stock-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs
Stock-based compensation expense is included on the Consolidated Statements of Income (Loss) and Comprehensive Income (Loss) based upon the job function of the employees receiving the grants as follows (in millions):
 
Three Months Ended 
 March 31,
 
2015
 
2014
Lease and Well
$
12.1

 
$
11.6

Gathering and Processing Costs
0.3

 
0.3

Exploration Costs
7.4

 
7.9

General and Administrative
13.3

 
15.8

Total
$
33.1

 
$
35.6

Weighted Average Fair Values and Valuation Assumptions
Weighted average fair values and valuation assumptions used to value stock option, SAR and ESPP grants during the three-month periods ended March 31, 2015 and 2014 are as follows:
 
Stock Options/SARs
 
ESPP
 
Three Months Ended 
 March 31,
 
Three Months Ended 
 March 31,
 
2015
 
2014
 
2015
 
2014
Weighted Average Fair Value of Grants
$
30.35

 
$
26.11

 
$
23.39

 
$
18.30

Expected Volatility
40.01
%
 
35.89
%
 
37.47
%
 
25.83
%
Risk-Free Interest Rate
0.82
%
 
0.84
%
 
0.11
%
 
0.09
%
Dividend Yield
0.73
%
 
0.48
%
 
0.72
%
 
0.44
%
Expected Life
5.3 years

 
5.3 years

 
0.5 years

 
0.5 years

Stock Options and SARs Transactions
The following table sets forth stock option and SAR transactions for the three-month periods ended March 31, 2015 and 2014 (stock options and SARs in thousands):
 
Three Months Ended 
 March 31, 2015
 
Three Months Ended 
 March 31, 2014
 
Number of
Stock
Options/SARs
 
Weighted
Average
Grant
Price
 
Number of
Stock
Options/SARs
 
Weighted
Average
Grant
Price
Outstanding at January 1
10,493

 
64.96

 
10,452

 
$
54.43

Granted
30

 
91.85

 
40

 
84.74

Exercised (1)
(459
)
 
47.25

 
(353
)
 
44.40

Forfeited
(96
)
 
77.96

 
(66
)
 
61.56

Outstanding at March 31 (2)
9,968

 
65.73

 
10,073

 
$
54.85

Vested or Expected to Vest (3)
9,586

 
65.09

 
9,619

 
$
54.44

Exercisable at March 31 (4)
4,882

 
49.85

 
4,314

 
$
44.00



(1)
The total intrinsic value of stock options/SARs exercised for the three months ended March 31, 2015 and 2014 was $20.1 million and $16.2 million, respectively. The intrinsic value is based upon the difference between the market price of EOG's common stock on the date of exercise and the grant price of the stock options/SARs.
(2)
The total intrinsic value of stock options/SARs outstanding at March 31, 2015 and 2014 was $279.5 million and $435.5 million, respectively. At March 31, 2015 and 2014, the weighted average remaining contractual life was 4.2 years and 4.4 years, respectively.
(3)
The total intrinsic value of stock options/SARs vested or expected to vest at March 31, 2015 and 2014 was $274.1 million and $419.8 million, respectively. At March 31, 2015 and 2014, the weighted average remaining contractual life was 4.1 years and 4.3 years, respectively.
(4)
The total intrinsic value of stock options/SARs exercisable at March 31, 2015 and 2014 was $204.5 million and $233.3 million, respectively. At March 31, 2015 and 2014, the weighted average remaining contractual life was 2.8 years and 3.0 years, respectively.
Restricted Stock and Restricted Stock Unit Transactions
The following table sets forth restricted stock and restricted stock unit transactions for the three-month periods ended March 31, 2015 and 2014 (shares and units in thousands):
 
Three Months Ended March 31, 2015
 
Three Months Ended March 31, 2014
 
Number of
Shares and
Units
 
Weighted
Average
Grant Date
Fair Value
 
Number of
Shares and
Units
 
Weighted
Average
Grant Date
Fair Value
Outstanding at January 1
5,394

 
$
64.39

 
7,358

 
$
49.54

Granted
438

 
87.93

 
384

 
94.01

Released (1)
(365
)
 
51.22

 
(838
)
 
24.47

Forfeited
(44
)
 
76.19

 
(55
)
 
57.73

Outstanding at March 31 (2)
5,423

 
$
67.08

 
6,849

 
$
55.04

 
(1)
The total intrinsic value of restricted stock and restricted stock units released for the three months ended March 31, 2015 and 2014 was $32.8 million and $79.0 million, respectively. The intrinsic value is based upon the closing price of EOG's common stock on the date the restricted stock and restricted stock units are released.
(2)
The total intrinsic value of restricted stock and restricted stock units outstanding at March 31, 2015 and 2014 was $497.3 million and $671.8 million, respectively.
Performance Units and Performance Stock Transactions
The following table sets forth performance unit and performance stock transactions for the three-month periods ended March 31, 2015 and 2014 (shares and units in thousands):

 
Three Months Ended 
 March 31, 2015
 
Three Months Ended 
 March 31, 2014
 
Number of
Shares and
Units
 
Weighted
Average
Grant Date
Fair Value
 
Number of
Shares and
Units
 
Weighted
Average
Grant Date
Fair Value
Outstanding at January 1
333

 
$
90.17

 
261

 
$
82.18

Granted

 

 

 

Released

 

 

 

Forfeited

 

 

 

Outstanding at March 31 (1)
333

 
$
90.17

 
261

 
$
82.18

 
(1)
The total intrinsic value of performance units and performance stock outstanding at March 31, 2015 and 2014 was $30.6 million and $21.9 million, respectively.